1954
DOI: 10.1111/j.1476-5381.1954.tb00822.x
|View full text |Cite
|
Sign up to set email alerts
|

Pharmacology of the Porphyrins and Porphobilinogen

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
7
0

Year Published

1955
1955
1981
1981

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 26 publications
(8 citation statements)
references
References 11 publications
(5 reference statements)
1
7
0
Order By: Relevance
“…There would be more of a tendency to polymerize at higher concentrations, and the products formed may have artifactually elevated [3H]NE uptake by causing membrane damage. Hematoporphyrin has been shown to be toxic to platelet membranes in vitro (27 (28,29). In nephrectomized rats receiving ALA or PBG intravenously, plasma concentrations of >5 mg/100 ml have been achieved without any alteration in blood pressure or symptoms of nervous system toxicity (23,30).…”
Section: Discussionmentioning
confidence: 99%
“…There would be more of a tendency to polymerize at higher concentrations, and the products formed may have artifactually elevated [3H]NE uptake by causing membrane damage. Hematoporphyrin has been shown to be toxic to platelet membranes in vitro (27 (28,29). In nephrectomized rats receiving ALA or PBG intravenously, plasma concentrations of >5 mg/100 ml have been achieved without any alteration in blood pressure or symptoms of nervous system toxicity (23,30).…”
Section: Discussionmentioning
confidence: 99%
“…Recently, the amount of free erythrocyte protoporphyrins (FEP) of renal dialysis patients has been shown to correlate with decreases in their motor nerve conduction velocities.8 T h e accumulation of porphyrins themselves has been shown to be nontoxic. 5 It has been suggested that patients with sickle cell anemia have somewhat elevated FEP levels as a result of their hemoglobinopathy. However, a random assessment of 27 SSA patients in our clinic failed to demonstrate elevated FEP in the absence of elevated blood lead levels.…”
Section: Discussionmentioning
confidence: 99%
“…In the past the demonstration that ALA and PBG are pharmacologically inert (Goldberg, Paton and Thompson, 1954) has led to suggestions that there is a deficiency of a substance required to protect nerve function, or of pyridoxine (Ridley, 1969), or that the abnormality of porphyrin precursor metabolism is merely a spectacular side effect of a more fundamental metabolic disturbance (Neuberger, 1968) possibly involving oxidation of NADH (Tschudy and Bonkowski, 1972). Recently Becker, Viljoen, and Kramer (1971) The porphyrias: a review that ALA inhibits brain tissue ATPase and have suggested that in the acute phase of porphyria ALA is taken up by nerve tissue and causes paralysis of conduction by inhibition of the Na+-K+-dependent ATPase, while Feldman, Levere, Lieberman, Cardinal, and Watson (1971) have reported that PBG in concentrations similar to those found in the cerebrospinal fluid during acute attacks, and one of its non-enzymically produced condensation products porphobilin, produce presynaptic neuromuscular inhibition.…”
Section: The Nature Of the Metabolic Abnormality In The Inherited Hepmentioning
confidence: 99%